A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

In June 2024, Abbott received a pair of clearances for its Libre Rio and Lingo CGM systems, both the company’s first to become available without a prescription. Based on its FreeStyle Libre ...

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose levels in real-time in non-diabetics.

A CGM helps me run marathons and do epic bike rides better than ever.

Abbott's revenue for the fourth quarter of 2024 ... in recent years as it is the first continuous glucose monitoring [CGM] system that is available without the need to see a doctor for a prescription.